MedPath
HSA Approval

PROPYLTHIOURACIL TABLETS BP 50 mg

SIN00772P

PROPYLTHIOURACIL TABLETS BP 50 mg

PROPYLTHIOURACIL TABLETS BP 50 mg

May 4, 1988

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence HolderTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

H03BA02

propylthiouracil

Manufacturer Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

PT ACTAVIS INDONESIA

Active Ingredients

PROPYLTHIOURACIL

50 mg

Propylthiouracil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PROPYLTHIOURACIL TABLETS BP 50 mg - HSA Approval | MedPath